Early changes in pyridoxine status of patients receiving isoniazid therapy.
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000596:Amino Acids / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D004796:Clinical Enzyme Tests; D003404:Creatinine / Q000652:urine; D004044:Dietary Proteins; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000652:urine; D009539:Nicotinic Acids; D009751:Nutritional Requirements; D011736:Pyridoxine / Q000378:metabolism* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000097:blood* / Q000188:drug therapy; D026681:Vitamin B 6 Deficiency / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D000596:Amino Acids; D004044:Dietary Proteins; D009539:Nicotinic Acids; D009536:Niacinamide; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D011736:Pyridoxine; D007538:Isoniazid